Delivery Order SPE2DR25D2105-SPE2DR26F5VDX
- Not listed
- The Defense Logistics Agency awarded a $1,101.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This contract, with an ultimate completion date of November 7, 2025, was awarded competitively with no set-aside designation. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,871.12 to AmerisourceBergen Drug Corp for Pantoprazole Sodium Delayed-Release 40 mg tablets (90-count supply). This competitively awarded, non-set-aside contract carries a firm fixed price and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The work is to be completed by August 21, 2025, with performance occurring at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.78 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets (1,000 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance executed from the contractor's Conshohocken, Pennsylvania facility and completion scheduled for November 18, 2025. The award represents a single delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,604.57 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This competitive delivery order, which is set to be completed by September 18, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium 40 mg delayed-release tablets, valued at $2,562.72. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets (1,000 count) with a ceiling value of $1,128.43. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $5,258.71. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $1,083.78. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $7,351.73. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded competitively. The contract is scheduled for ultimate completion on November 6, 2025, and performance will take place at AmerisourceBergen's corporate office...
- SPE2DR25D2105Indefinite Delivery Contract
- SPE2DR25D2105-SPE2DR26F5VDXDelivery Order
The Defense Logistics Agency awarded a $1,789.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pantoprazole Sodium delayed-release 40 mg tablets (90-count supply) on January 2, 2026, with completion scheduled for January 5, 2026. The award was made on a competitive basis without any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC serves as a prime vendor agreement enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. This particular delivery order for the gastroenterology medication reflects the company's role in supplying routine pharmaceutical commodities to the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates its capacity to fulfill diverse medical procurement requirements across multiple therapeutic domains, from specialty medications to generic pharmaceuticals and medical devices, supporting the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/1/26 |